At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete improvement in tissue ...

Elizabeth Spencer, MD, discusses various treatments for eosinophilic esophagitis (EoE) across age groups, highlighting the role of dietary modifications, proton pump inhibitors, swallowed ...

Medically reviewed by Qin Rao, MD Common foods that trigger EoE symptoms include eggs, dairy, soy, gluten, tree nuts, and fish.Males are three times more likely to develop EoE than females.There's no ...

The US Food and Drug Administration approvals of dupilumab (Dupixent, Regeneron/Sanofi) for adults and children with eosinophilic esophagitis (EoE) affirmed the safety and efficacy of the drug, which ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted an orphan drug designation to ’1104 from Revolo Biotherapeutics, a first-in-class ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Takeda Pharmaceuticals’ Eohilia as the “first and only oral therapy” for treatment of ...

Despite high hopes, a drug that wipes out the namesake cell type associated with the disease eosinophilic esophagitis (EoE) doesn't make patients feel better and doesn't reverse tissue damage in their ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent, Regeneron/Sanofi) for the treatment of eosinophilic esophagitis (EoE) in children aged 1-11 years and weighing ≥ 15 kg. It ...

DelveInsight's,“ Eosinophilic Esophagitis Pipeline Insight 2024 ” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It ...

The 3 main treatments for EoE are medication, dietary therapy, or mechanical dilation of the esophagus. Patients should be evaluated individually to address their most problematic complaints first, ...

While dupilumab's use has been extended to children under 12, benralizumab shows no benefit to patients with eosinophilic esophagitis (EoE). Despite high hopes, a drug that wipes out the namesake cell ...